Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > On second thought
View:
Post by tylerreddick on Nov 01, 2024 10:51am

On second thought

This was in their last news release:

" We are carefully assessing the most favorable markets for the initial launch to ensure long-term success. Our internal analysis, grounded in market data, suggests that a successful launch in just one key region could bring Sirona to profitability as early as 2025. "

And here:


https://drive.google.com/file/d/1jI2T-NE1htKzdSWOXnZE8vSoHlDKY7g9/view

They focus on South Korea. So I guess that is where we launch first. Is that true? Will that make SBM profitable in 2025? Only time will tell.

But too bad we always have to read between the lines.
Comment by tylerreddick on Nov 01, 2024 6:26pm
If we really are going to launch GPM in South Korea within months, it sure would be nice if Howie issued an actual news release instead of on twitter, where only a handful of people see it, and they are already familiar with the story. Too bad he doesn't read this board, but I suppose he doesn't like to hear what a failure he has been leading this company. Hopefully, once we start making ...more  
Comment by Pandora on Nov 01, 2024 7:29pm
Is Gredeco a precursor to TF Chem? Also is there any significance to the date of December 2010 in the bottom right corner?
Comment by moneycollector on Nov 02, 2024 12:19am
Gredeco is a french research and evaluation company. I suppose the results are from the original testing of 1326. So it looks Howie just came up with the "great" new idea SK people could be interested in it's GlicoCarrot...
Comment by Pandora on Nov 01, 2024 7:37pm
That link is dated October 31, 2024. I don't recall seeing it as a news release -- particularly on Stockhouse. Not on Stockwatch either.
Comment by Turtle4 on Nov 02, 2024 3:01am
News releases must be true. But on X you can post everything you want. Thats why there is no news Release.
Comment by Pareto8020 on Nov 05, 2024 9:39am
What I want to know is how can they drop a news release on X and not be offside with reporting requirements of any of the exchanges they are on? They have been struggling to put any kind of news out and now they have completed a clinical trial and seem to have a partner lead in Korea and they announce that by posting a doc on X?  WTF are they doing?  Seriously they need to get some ...more  
Comment by tylerreddick on Nov 05, 2024 10:21am
Well, it really wasn't actual "news". The clinical trail mentioned is not new, and they haven't actually signed a material contract with anyone in South Korea. it is all just speculation, so an offical news release isn't required. Besides, we don't have the money to pay for one.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities